In October 2024, the Corporation announced the completion of the sale of 8,000 shares of TauRx Pharmaceuticals Ltd. to a private investor at a price of US$125.00 per share for proceeds of US$1.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback